ArticleFrontiers in medicine2025
Case Report: Liquid-based cytology diagnosis of pulmonary mucormycosis.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mucormycosis is an infrequent yet life-threatening opportunistic fungal infection, typically secondary to diabetic ketoacidosis. Owing to its non-specific clinical presentation and auxiliary test findings, timely diagnosis remains difficult. While fungal culture, direct smear, histopathological biopsy, and molecular diagnostic techniques are available, cytological evaluation and histopathological biopsy remain the principal modalities in clinical settings. Notably, cytological identification of mucorales remains rare. Case presentation: A 41-year-old male presented with a 20-day history of productive cough and fever, accompanied by a recent onset of hemoptysis. His medical history included type 2 diabetes mellitus. Diagnostic confirmation of mucormycosis was achieved through conventional cytological smear, liquid-based cytology, cell block preparation, tissue biopsy, and specialized staining techniques. Pulmonary mucormycosis was ultimately diagnosed. Conclusion: This report documents a case of pulmonary mucormycosis identified via conventional cytological smear, liquid-based cytology, and cell block preparation. Liquid-based cytology and cell block techniques offered a non-invasive and more expedient approach, highlighting their value in the early identification and intervention of mucormycosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.